Donor age ≥50 years combined with donor-CI ≥3 identifies a high-risk cohort for adverse outcomes after allogeneic hematopoietic stem cell transplantation in B-cell acute lymphoblastic leukemia.
APA
Wu N, Kong J, et al. (2026). Donor age ≥50 years combined with donor-CI ≥3 identifies a high-risk cohort for adverse outcomes after allogeneic hematopoietic stem cell transplantation in B-cell acute lymphoblastic leukemia.. Bone marrow transplantation. https://doi.org/10.1038/s41409-026-02844-x
MLA
Wu N, et al.. "Donor age ≥50 years combined with donor-CI ≥3 identifies a high-risk cohort for adverse outcomes after allogeneic hematopoietic stem cell transplantation in B-cell acute lymphoblastic leukemia.." Bone marrow transplantation, 2026.
PMID
41851370
같은 제1저자의 인용 많은 논문 (5)
- Bridging With Chimeric Antigen Receptor T-Cell Therapy or Chemotherapy to Allo-HSCT in B-ALL: A Comparison of Treatment Complications and Survival.
- AGR2 promotes tumor progression by regulating macrophage polarization via the CD98hc-xCT/p-ERK pathway.
- Gene expression profile, and role of baicalein in the inhibition of thyroid cancer.
- The impact of pre-existing autoimmune diseases in myelodysplastic syndrome patients undergoing allogeneic hematopoietic stem cell transplantation: A retrospective cohort study.
- High-affinity poly-cytosine DNA modulated metal-organic framework-DNA interactions and their application in detection of hepatocellular carcinoma biomarker.